期刊文献+

Preparation,Characterization of Hydrophobic Drug in Combine Loaded Chitosan/Cyclodextrin/Trisodium Citrate Nanoparticles and in vitro Release Study

Preparation,Characterization of Hydrophobic Drug in Combine Loaded Chitosan/Cyclodextrin/Trisodium Citrate Nanoparticles and in vitro Release Study
下载PDF
导出
摘要 Chitosan/cyclodextrin/trisodium citrate(CS/CD/TSC) nanoparticles with ibuprofen(IBU) loaded were prepared via the ionic cross-linking method, with trisodium citrate selected as the cross-linking agent. The drug-loading capacity, particle size, zeta potential and surface morphology of the obtained nanoparticles were inves tigated. The results show a good drug-loading capacity. The prepared nanoparticles were spherical in shape with an average size of 293.7 nm and a zeta potential of +30.72 mV. The in vitro release studies show that the controlled re lease of IBU from the nanoparticles was followed. The drug release from CS/β-CD/TSC nanoparticles followed non-Fickian or anomalous diffusion. Chitosan/cyclodextrin/trisodium citrate(CS/CD/TSC) nanoparticles with ibuprofen(IBU) loaded were prepared via the ionic cross-linking method, with trisodium citrate selected as the cross-linking agent. The drug-loading capacity, particle size, zeta potential and surface morphology of the obtained nanoparticles were inves tigated. The results show a good drug-loading capacity. The prepared nanoparticles were spherical in shape with an average size of 293.7 nm and a zeta potential of +30.72 mV. The in vitro release studies show that the controlled re lease of IBU from the nanoparticles was followed. The drug release from CS/β-CD/TSC nanoparticles followed non-Fickian or anomalous diffusion.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2012年第1期166-170,共5页 高等学校化学研究(英文版)
基金 Supported by the Key Scientific and Technological Projects of Chongqing Science and Technology Commission, China (No.CSTC2010AC5050) the Chongqing University(China) Postgraduates’ Science and Innovation Fund (No.CDJXS10220008)
关键词 CHITOSAN CYCLODEXTRIN NANOPARTICLE Ibuprofen(IBU) Chitosan Cyclodextrin Nanoparticle Ibuprofen(IBU)
  • 相关文献

参考文献19

  • 1Simovic S., Hui H., Song Y. M., Davey A. K., Rades T., Prestidgeet C. A., J. Control. Release., 2010, 143, 367.
  • 2Levis K. A., Lane M. E., Corrigan O. I., Int. J. Pharm., 2003, 253, 49.
  • 3Terao K., Nakata D., Fukumi H., Schmidb G., Arimac H., Nutr. Res., 2006, 26, 503.
  • 4Filippa M., Sancho M. I., Gasull E., J. Pharmaceut. Biomed., 2008, 48, 969.
  • 5Atyabi F., Moghaddam F. A., Dinarvand R., Zohuriaan-Mehr M. J., Ponchelet G., Carbohyd. Polym., 2008, 74, 59.
  • 6Zheng L., Jiang F. H., Dong P. J., Zhuang Q. F., Li F., Chem. Res. Chinese Universities, 2010, 26(3), 355.
  • 7Wang X., Wu Z. M., Zhang X. G., Zheng C., Wang Z., Li C. X., Chem. J. Chinese Universities, 2008, 29(4), 851.
  • 8Huang H. N., Li C., Xie L. S., Huang H. Q., Chem. J. Chinese Uni- versities, 2008, 29(8), 1592.
  • 9Li J. F, Zhang L., Li J. F., Zou Q., Yang W. H., Li Y. B., Chem. J. Chinese Universities, 2008, 29(9), 1874.
  • 10Wang Y. S., Han Y. L., Li Y. X., Wang Y. M., Chem. J. Chinese Uni- versities, 2007, 28(6), 1092.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部